Synergy Spine Solutions

Synergy Spine Solutions, founded in 2005, is a medical device company focused on developing advanced solutions for spine surgery. The company operates in the surgical devices sector, specifically targeting the artificial cervical disc replacement market for patients with degenerative disc disease. Its business model revolves around the development, clinical trial execution, and commercialization of its proprietary spine technologies to healthcare organizations and surgeons. The company generates revenue through the sale of its products in approved markets, which currently include Europe, Australia, Canada, and other regions outside the United States, with plans to enter the U.S. market pending FDA approval.

The company's flagship product is the Synergy Disc®, an artificial cervical disc designed to address degenerative disc disease. A key feature that distinguishes the Synergy Disc from traditional ball-and-socket replacements is its ability to not only preserve motion but also to restore or maintain proper spinal alignment and balance, a concept the company calls "Balance Control Arthroplasty". The device features a lordotic core, titanium alloy endplates, and a design that mimics the natural motion of a healthy cervical disc, including flexion, extension, lateral bending, and axial rotation. Clinical studies suggest the Synergy Disc can effectively increase disc space height and is unique in its ability to alter device angulation. The device is undergoing extensive multi-center clinical trials in the U.S. to evaluate its safety and effectiveness compared to the standard Anterior Cervical Discectomy and Fusion (ACDF) procedure, a critical step for gaining FDA approval.

The leadership team, led by CEO Josh Butters, has extensive experience in the medical device industry. Butters has over 20 years of experience in both large and small medical device companies, with a track record in innovation and asset commercialization. The team also includes Dr. Neil Duggal, a neurosurgeon who performed the first cervical disc replacement in North America and serves as a consultant and Chief Medical Officer. Tim Hein, the Vice President of Sales & Marketing, brings significant experience from leadership roles at major spine companies like LDR Spine, Medtronic, and Zimmer Biomet. The company has secured significant funding to advance its clinical trials and commercialization efforts, including a $30 million Series A round in January 2024, led by Amzak Health. Keywords: artificial cervical disc, degenerative disc disease, spine surgery, motion preservation, spinal alignment, cervical arthroplasty, medical device, Synergy Disc, ACDF alternative, spine technology, cervical TDR, Balance Control Arthroplasty, lordotic core, surgical devices, orthopedics, spine kinematics, motion restoration, spinal balance, neurosurgery, clinical trials